Dr. Benjamin Pearce
Vascular Surgery (Vascular Surgery Physician)
- Medicare participating
At a glance
- Medical school
- Duke University School of Medicine (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 432
Licensed in Alabama since 2007, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: Duke University School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular Surgery Physician primary
AL license 28114 (first issued 2007; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Alabama Hospital Birmingham, AL
- Riverview Regional Medical Center Gadsden, AL
Medical groups
- University of Alabama Health Services Foundation, PC (2,814 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 432
- Services billed
- 879
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 10-19 minutes | 152 | 132 |
| Ultrasound study of arm and leg arteries | 77 | 75 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 62 | 62 |
| Ultrasound of both sides of head and neck blood flow | 60 | 59 |
| Established patient office or other outpatient visit, 20-29 minutes | 33 | 30 |
| New patient office or other outpatient visit, 45-59 minutes | 30 | 30 |
| Complete ultrasound study of arm and leg arteries | 27 | 27 |
| Review by radiologist of arm or leg artery image | 25 | 21 |
| Ultrasound of one leg arteries or artery grafts | 22 | 21 |
| Ultrasonic guidance for blood vessel access | 18 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Birmingham, AL | 127 |
| Rosuvastatin Calcium Other prescribers in Birmingham, AL | 67 |
| Xarelto (rivaroxaban) Other prescribers in Birmingham, AL | 62 |
| Gabapentin Other prescribers in Birmingham, AL | 59 |
| Eliquis (apixaban) Other prescribers in Birmingham, AL | 54 |
| Atorvastatin Calcium Other prescribers in Birmingham, AL | 45 |
| Oxycodone Hcl Other prescribers in Birmingham, AL | 37 |
| Cilostazol Other prescribers in Birmingham, AL | 29 |
| Simvastatin Other prescribers in Birmingham, AL | 16 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 31 payments worth $8,183 in total to this clinician.
| W. L. Gore & Associates, Inc. | $6,861 |
|---|---|
| Penumbra, Inc. | $547 |
| Integra Lifesciences Corporation | $307 |
| Medtronic, Inc. | $163 |
| Cook Medical LLC | $128 |
| Mentor Worldwide LLC | $86.15 |
| Ethicon US, LLC | $55.26 |
| Boston Scientific Corporation | $35.38 |
| Consulting Fee | $5,700 |
|---|---|
| Food and Beverage | $2,463 |
| Travel and Lodging | $20.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| W. L. Gore & Associates, Inc. Feb 14, 2025 | Consulting Fee GORE VIABAHN Endoprosthesis; GORE VIABAHN VBX Balloon Expandable Endo · Devices | $2,280 |
| W. L. Gore & Associates, Inc. Feb 14, 2025 | Consulting Fee GORE VIABAHN Endoprosthesis; GORE VIABAHN VBX Balloon Expandable Endo · Devices | $1,710 |
| W. L. Gore & Associates, Inc. Feb 14, 2025 | Consulting Fee GORE VIABAHN VBX Balloon Expandable Endo; GORE VIABAHN Endoprosthesis · Devices | $1,710 |
| Penumbra, Inc. Jan 22, 2025 | Travel and Lodging Indigo System · Peripheral Intervention · travel to Saint Thomas, Virgin Islands | $20.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $26,297 in research payments for these studies, mostly to the institutions running them.
- Global Registry for Endovascular Aortic Treatment (GREAT)
W. L. Gore & Associates, Inc. · Active, not recruiting · NCT01658787 - RELAYPRO-A
Bolton Medical Inc
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.